Jeri Kim,Associate Professor of The University of Texas MD Anderson Cancer Center, USA. Fundamental to her research is a clinical framework for studying low-volume prostate cancer to delineate underlying molecular mechanisms involved in prostate carcinogenesis and disease progression. She have been a Principal Investigator (PI) or Co-investigator for studies funded by the NCI, grants from private nonprofit groups, and internal grants—and perspective that best comes from experience: “dual citizenship” in clinical medicine and basic science. She have expanded my technical expertise in laser capture microdissection, oligonucleotide microarrays, and immunohistochemical studies (NCI-funded [R21 and R03] studies of prostate cancer multifocality); managed both clinical and tissue studies in an examination of the Prostate Cancer Prevention Trial finding of higher grade cancers in men taking finasteride (as PI of an N01 trial); and led tissue and clinical studies in a longitudinal study of early-stage prostate cancer in one of the largest active surveillance cohorts in the world (as PI). Building a multidisciplinary team of collaborators—pathologists, surgeons, biostatisticians, and oncologists—over time has streamlined operations, benefiting team members, the students who engage in the work, and the translations to improve clinical practice that we are attempting.
我们专注于根据您的具体需求（包括演讲议题、会议日期及活动预算等），为您精准匹配各领域专业嘉宾。为高效服务，建议您提前准备好详细活动信息，并拨打客服电话：18911802888（工作日9:00-18:00）。
温馨提示：本服务仅限嘉宾邀约相关事宜，其他需求暂不处理，感谢您的理解与配合。